Continuing Education Activity

Amniotic band syndrome (ABS) comprises various congenital anomalies, which include disruption, deformation, and malformations of organs that were intended to develop normally. Amniotic band syndrome should be called a sequence rather than a syndrome because the pattern of anomalies in ABS are related to an insult that can result from multiple etiologies, whereas a syndrome refers to patterns of congenital anomalies that are known to result from single etiology (e.g., Turner syndrome is due to XO chromosomal anomaly). Likewise, ABS has many names amnion rupture sequence, ADAM complex (amniotic deformities/adhesions/mutilations), amniotic band disruption complex, congenital constricting bands, terminal transverse defects, and Streeter anomaly. This activity reviews amniotic band syndrome in newborns and highlights the interprofessional team's role in taking care of infants with amniotic band syndrome.

Objectives:

• Identify the etiology of amniotic band syndrome.

• Describe the evaluation of amniotic band syndrome.

• Outline the treatment options available for amniotic band syndrome.

• Review interprofessional team strategies for improving care coordination and communication to advance the care of infants with amniotic band syndrome and improve outcomes.

Introduction

Amniotic band syndrome (ABS) comprises various congenital anomalies, which include disruption, deformation, and malformations of organs that were intended to develop normally (see Image. Amniotic Band Syndrome).[1] Amniotic band syndrome should be called a sequence rather than a syndrome because the pattern of anomalies in ABS are related to an insult that can result from multiple etiologies, whereas a syndrome refers to patterns of congenital anomalies that are known to result from single etiology (e.g., Turner syndrome is due to XO chromosomal anomaly). Likewise, ABS has many names: amnion rupture sequence, ADAM complex (amniotic deformities/adhesions/mutilations), amniotic band disruption complex, congenital constricting bands, terminal transverse defects, and Streeter anomaly.[2]

Etiology

There is no known clear etiology of amniotic band syndrome. But it is thought that rupture of amnion early in pregnancy results in the development of multiple loose strands (amniotic bands) that adhere to and/or entangle the fetus.[1][3] Constriction of otherwise normally developing organs results in constriction rings, some severe cases leading to vascular disruption and could potentially result in amputation of the involved anatomic structure. Adherence, even without constriction, can have adverse mechanical effects that result in malformation or deformation. The cause of the rupture of amnion is unknown in most cases. But in some cases, iatrogenic invasive procedures like chorionic villus sampling can lead to ABS-like clinical presentation.

The above mentioned etiological reasoning does not explain all ABS findings, as in some cases, the affected anatomic structures are internal visceral organs and have a histologically intact amniotic lining. In these cases, disruption of fetal blood flow unrelated to bands is thought to be the primary cause. This vascular insult could result from misoprostol exposure in the first trimester and or chorionic villus sampling before 10 weeks of gestation.

For a few cases, neither the amniotic band nor vascular disruption is thought to result from a genetic mutation. As almost all ABS cases in twins have been seen in monozygotic twins, suggesting a genetic correlation.[4]

Epidemiology

The estimated incidence of amniotic band syndrome ranges between 1 in 1000 to 1 in 15000 live births and 1 in 70 stillbirths.[5] Both male and female newborns are equally affected.

There is no known inheritance pattern. Almost all cases are sporadic, but few examples of familial ABS have been reported primarily with monozygotic twin gestation.

Pathophysiology

Although not completely understood, as the embryo grows between the amnion and the chorion, the amnion eventually obliterates the extracoelomic space, the incomplete obliteration of the extracoelomic space may render the amnion fragile and susceptible to rupture. The ruptured amnion could attach itself to body parts, leading to clinical features of amniotic band syndrome. Theories of defective germ plasma and vascular disruption have been proposed to explain the pathophysiology, especially in cases involving internal organs.

History and Physical

Clinical presentation can classify into four major categories.

• Constrictive rings
• Limb defects
• Neural or spine defects
• Craniofacial defects

Constriction rings and limb or digital amputation are the most common findings, present in at least 80 percent of cases. The amniotic bands may be present, confined to the skin or soft tissue, and may extend deep into the tissue. If constriction results in amputation in-utero, then the amputated part is usually resorbed and not visible following birth.

Limb defects include constriction ring of an extremity with swelling of distal part, absence of distal portions of one or more fingers and toes, especially the central digits, contractures, or fracture. Lower extremities are affected more commonly than upper, and the thumb is usually spared due to the protection of the palm in-utero. 

While atypical, craniofacial abnormalities, such as encephalocele, facial clefts, and cleft lip/cleft palate may be present. Spinal defects and scoliosis have also been known to occur with ABS.

Evaluation

Due to the extensive clinical presentation and heterogeneous etiology, diagnosing amniotic band syndrome could be challenging, especially prenatally. ABS can be suspected prenatally as early as the first trimester if constriction, amputation, or deformation of major anatomic structures are present. Distal limb edema can help make a diagnosis of ABS prenatally. In very few cases, a strand of amniotic fibrous tissue could be seen attached to tissues and restricting the free movement of the fetus in-utero.

Postnatally ABS should be suspected in newborns with visible constrictions, amputations, non-midline, and unusually located craniofacial or body wall defects. Investigation of the fresh fetal membranes and placenta is important in cases where amniotic bands are not visibly present in newborns.

Treatment / Management

There are no set guidelines for the management of amniotic band syndrome when diagnosed prenatally. Regardless of the therapeutic approach chosen, all patients should receive counseling about fetal abnormalities detected and the possibility of other hidden abnormalities. Amniocentesis, for chromosomal microarray (CMA), is indicated if results will affect pregnancy decision making. Consulting with concerned subspecialists is ideally recommended. In cases of lethal anomalies, post-natal palliative care should also be a topic of discussion.

The in-utero intervention of amniotic band lysis can potentially slow down the progression of the effects of constriction and restore normal flow to the downstream structures. There is a hypothesis that fetal limb recovery is more likely after fetal intervention than postnatal recovery because of the plasticity tissue healing during fetal life. Although fetoscopic intervention may restore blood flow and save the limb, plastic surgery may still be necessary after birth. However, the efficacy of this intervention is unknown, as there are no set criteria for the selection of candidates and a lack of clinical studies.[6]

There are no standard guidelines for the management of pregnancy complicated with fetal ABS. Follow-up, ultrasound, and intervention are individually tailored and depend on the severity of ABS complications.[7]

Postnatal management includes a thorough physical exam, and if needed, imaging studies to clearly describe the extent of ABS. Relief of constriction rings postnatally may help salvage some limb function by relieving venous pressure. Vascular comprise diagnosed postnatally may require urgent surgical intervention.

Differential Diagnosis

Differential diagnosis of amniotic bands divides into two main groups.

1. Uterus and placental anomalies:

• Synechiae and septa - Uterine synechiae are intrauterine adhesions typically resulting at previous intrauterine surgical site or infection. Uterine septa are congenital malformations. Synechiae and septa do not restrict fetal movement and are not associated with fetal anomalies like ABS. 
• Residual gestational sac - A residual gestational sac left after the death of the fetus in case of twin pregnancy. 
• Circumvallate placenta - Circumvallate placenta refers to a placenta with an unusually small chorionic plate, but with the growth of extrachorial placental tissue, which also does not restrict fetal movement and not cause ABS.

     2. Limb Amputations - there are other causes of congenital absence of limbs:

• Syndromes and teratogens - There are numerous syndromes with associated congenital limb anomalies. An example is absent thumb and radius syndrome. Some of the limb anomalies could also be due to teratogenic substances.

Prognosis

The prognosis of a newborn affected by amniotic band syndrome depends on the extent of the defects, from minor cosmetic defects to lethal involvement of vital organs. 

Complications

Amniotic band syndrome carries correlations with miscarriages, preterm, and stillbirths.

Deterrence and Patient Education

Amniotic band syndrome/amniotic band sequence (ABS) is a highly variable spectrum of anomalies affecting various anatomical structures during fetal life.[8]

Etiology is multifactorial with multiple proposed mechanisms; the most widely accepted theories include amniotic band attachment, vascular disruption, and rare genetic mutation.

There are four main categories of anatomical defects – constriction rings, limb defects, spine/neural defects, and craniofacial defects.

It is diagnosable prenatally. The extent of ABS and severity of defect dictates the care of pregnant mothers as there are no clear published guidelines. In-utero lysis of amniotic band can salvage limb function, but again there are no guidelines for selecting patients. Postnatal treatment involves the release of constricting rings, if possible, to save the distal limb. ABS can also lead to lethal deformation of vital internal organs in rare cases.

Enhancing Healthcare Team Outcomes

Management of amniotic band syndrome begins with early fetal diagnosis and early collaboration between obstetrics, neonatal-perinatal specialist, and maternal-fetal medicine specialist; this may help achieve the best outcome for individual patients. Management of newborns affected by amniotic band syndrome requires careful examination and interprofessional team involvement. There is a lack of strong evidence for any particular approach. Depending on the anatomical structure involved, consult with a pediatric general surgeon, orthopedic surgeon, and/or craniofacial surgeon may be needed. Nurses monitoring these infants have to constantly monitor for pulses, warmth, and cyanosis and report any deviation from normal to the attending physician and specialists on the team. The specialized neonatal inpatient nurses should assist the clinician in educating the parents in the patient's care. While extremity constriction may be easy to visualize, if the bands involve the chest, abdomen, or neck, one may require imaging studies, which would then include a radiologist as well. 

Lastly, parents should receive counseling from the nursing and clinical interprofessional team that most ABS cases are sporadic with no known re-occurrence risk unless in cases of familial ABS. In instances of cosmetic deformity, psychological counseling may also be necessary for the patients and/or their families.

ABS requires an interprofessional team approach, including physicians, specialists, specialty-trained nurses, and counselors, all collaborating across disciplines to achieve optimal patient results. [Level 5]